The U.S. Food and Drug Administration (FDA) recently recommended that clinicians be more conservative when they prescribe chronic kidney disease (CKD) patients with drugs that treat red blood cell deficiencies.

THOUSAND OAKS, Calif., Dec. 15, 2011 /PRNewswire/ -- Kevin W.

THOUSAND OAKS, Calif., June 24, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced today that the U.S.

Cites increased risk of cardiovascular events when used to treat chronic kidney disease SILVER SPRING, Md., June 24, 2011 /PRNewswire-USNewswire/ -- The U.S.

THOUSAND OAKS, Calif., May 18, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that data from studies involving nine Amgen products will be presented at the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting, June 3 - 7, 2011 in Chicago.